Position history for PRICE T ROWE ASSOCIATES INC /MD/'s holdings in MOONLAKE IMMUNOTHERAPEUTICS
PRICE T ROWE ASSOCIATES INC /MD/ holds 1.3M shares of MLTX (MOONLAKE IMMUNOTHERAPEUTICS), worth $24.1M as of 2026-Q1. The position was increased (+34.9% shares). MLTX represents 0.0% of PRICE T ROWE ASSOCIATES INC /MD/'s portfolio.
Current Value
$24.1M
Current Shares
1.3M
Total Value Change
-$88.5M
Total Shares Change
-1.3M
Other major holders of MLTX: FMR LLC, Avoro Capital Advisors LLC
Increased |
| 1.3M |
+34.9% |
| $24.1M |
| 0.0% |
| $17.69 |
37 |
| 2025-Q4 | Increased | 959,553 | +16.6% | $12.6M | 0.0% | $13.21 | 32 |
| 2025-Q3 | Decreased | 822,957 | -68.5% | $5.9M | 0.0% | $6.24 | 0 |
| 2025-Q2 | Decreased | 2.6M | -12.1% | $123.3M | 0.0% | $47.52 | 0 |
| 2025-Q1 | Decreased | 3M | -11.1% | $116.2M | 0.0% | $39.86 | 0 |
| 2024-Q4 | Increased | 3.3M | +12.2% | $181.1M | 0.0% | $53.02 | 34 |
| 2024-Q3 | Increased | 3M | +16.4% | $150.3M | 0.0% | $49.40 | 35 |
| 2024-Q2 | Increased | 2.6M | +19.9% | $112.6M | 0.0% | $43.97 | 36 |